##  [Mexico's Regulation: The National Center for Pharmacovigilance and Technovigilance (CENAFyT) is Created -Drugs](/index%2ephp/mandate/mexicos-regulation-the-national-center-for-pharmacovigilance-and-technovigilance-cenafyt-is-created-drugs) 

March 9, 2026

The document outlines the creation of CENAFyT and its new role in coordinating and improving the monitoring of the safety of medicines in Mexico.

**This document covers the following information:**

- CENAFyT’s responsibility for overseeing pharmacovigilance activities related to medicines
- Strengthening of reporting, supervision, and investigation of adverse drug reactions
- Updating and enforcing technical regulations, specifically NOM-220-SSA1-2016 for medicine safety
- Coordination among all members of the National Pharmacovigilance System to ensure effective detection and management of risks associated with medicines
- Commitment to protecting public health by ensuring that all medicines on the market are safe and effective



[Consult Now](/webform/consult%0A?url=https://preprod.freyrsolutions.com/index%2ephp/markdownify/node/12997)



Source

[https://www.gob.mx/cofepris/es/articulos/surge-el-centro-nacional-de-farmacovig…](https://www.gob.mx/cofepris/es/articulos/surge-el-centro-nacional-de-farmacovigilancia-y-tecnovigilancia-cenafyt?idiom=es)

 

 

Select Mandate HA

[COFEPRIS](/index%2ephp/mandate-by-ha/cofepris)

 

Select Mandate Function

[Country Regulatory Affairs](/index%2ephp/mandate-by-function/country-regulatory-affairs)